Evidence map›Paper›PMID 36894746›Full record

ArticleHypertension research : official journal of the Japanese Society of Hypertension2023

Association between total cerebral small vessel disease score and cognitive function in patients with vascular risk factors.

Megumi Hosoya, Sono Toi, Misa Seki, Moeko Saito, Takao Hoshino, Hiroshi Yoshizawa, Kazuo Kitagawa

Abstract read
PubMed Publisher
In one paragraph

Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. The brain and hypertension: how the brain regulates and suffers from blood pressure.Hypertension research : official journal of the Japanese Society of Hypertension · 2025
    Review
  8. Article
  9. Small vessels cause big problems.Hypertension research : official journal of the Japanese Society of Hypertension · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Megumi HosoyaDepartment of Neurology, Tokyo Women's Medical University Hospital, Tokyo, Japan.
Sono ToiDepartment of Neurology, Tokyo Women's Medical University Hospital, Tokyo, Japan.
Misa SekiDepartment of Neurology, Tokyo Women's Medical University Hospital, Tokyo, Japan.
Moeko SaitoDepartment of Neurology, Tokyo Women's Medical University Hospital, Tokyo, Japan.
Takao HoshinoDepartment of Neurology, Tokyo Women's Medical University Hospital, Tokyo, Japan.
Hiroshi YoshizawaDepartment of Neurology, Tokyo Women's Medical University Hospital, Tokyo, Japan.
Kazuo KitagawaDepartment of Neurology, Tokyo Women's Medical University Hospital, Tokyo, Japan. kitagawa.kazuo@twmu.ac.jp.
Tokyo Women's Medical University Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertension is the most important risk factor for cerebral small vessel disease (SVD). In this cross-sectional study, we tested the independent association of cerebral SVD burden with global cognitive function and each cognitive domain in patients with vascular risk factors. The Tokyo Women's Medical University Cerebral Vessel Disease (TWMU CVD) registry is an ongoing prospective, observational registry in which patients with any evidence of CVD in magnetic resonance imaging (MRI) and at least one vascular risk factor were consecutively enrolled. For SVD-related findings, we evaluated white matter hyperintensity, lacunar infarction, cerebral microbleeds, enlarged perivascular space, and medial temporal atrophy. We used the total SVD score as the SVD burden. They underwent the Mini-mental State Examination (MMSE) and Japanese version of the Montreal Cognitive Assessment (MoCA-J) global cognitive tests, and each cognitive domain was evaluated. After excluding patients without MRI T2* images and those with MMSE score <24, we analyzed 648 patients. The total SVD score was significantly associated with MMSE and MoCA-J scores. After adjustment for age, sex, education, risk factors, and medial temporal atrophy, the association between the total SVD score and MoCA-J score remained significant. The total SVD score was independently associated with attention. In conclusion, the total SVD score, cerebral SVD burden, was independently association with global cognitive function and attention. A strategy to reduce SVD burden will have the potential to prevent cognitive decline. A total of 648 patients with any evidence of cerebral small vessel disease (SVD) in MRI and at least one vascular risk factor underwent Mini-mental State Examination (MMSE) and Japanese version of the Montreal Cognitive Assessment (MoCA-J) global cognitive tests. The total SVD scores count the presence of each SVD-related findings (white matter hyperintensity, Lacunar infarction, cerebral microbleeds and enlarged perivascular space), ranging from 0 to 4, as the SVD burden. Total SVD scores were significantly associated with MoCA-J scores (r = -0.203, P < 0.001). After adjustment for age, sex, education, risk factors, and medial temporal atrophy, the association between the total SVD score and global cognitive scores remained significant.

Indexed as

Cerebral Small Vessel DiseasesCognitive DysfunctionStroke, LacunarAtrophyCerebral HemorrhageCerebral InfarctionCognitionCross-Sectional StudiesFemaleHumansMagnetic Resonance ImagingProspective StudiesRisk FactorsAttentionCognitive functionTotal small vessel disease scoreWhite matter hyperintensity

Identifiers

PMID36894746
OpenAlexW4323665855

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.